Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer PYSZCZYMUKA GREG
Apr 2 16:48 ET
Aytu BioPharma | 8-K: Current report
Feb 14 16:21 ET
Aytu BioPharma | 10-Q: Quarterly report
Feb 14 16:17 ET
Aytu BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Feb 13 16:31 ET
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer PYSZCZYMUKA GREG
Jan 2 00:00 ET
Aytu BioPharma | 8-K: Current report
Nov 17, 2023 16:10 ET
Aytu BioPharma | 8-K: Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
Nov 14, 2023 16:10 ET
Aytu BioPharma: Q1 2024 Earnings Report
Nov 14, 2023 16:05 ET
Aytu BioPharma | 8-K: Current report
Oct 26, 2023 08:05 ET
Aytu BioPharma | 10-K: FY2023 Annual Report
Oct 12, 2023 14:50 ET
Aytu BioPharma | 8-K: Current report
Oct 6, 2023 16:30 ET
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer PYSZCZYMUKA GREG
Oct 3, 2023 16:37 ET
Aytu BioPharma | NT 10-K: Others
Sep 29, 2023 16:15 ET
Aytu BioPharma | 8-K: Current report
Sep 27, 2023 16:20 ET
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Director JAIN ABHINAV
Aug 18, 2023 18:27 ET
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Disbrow Jarrett
Aug 15, 2023 20:57 ET
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Director JAIN ABHINAV
Aug 15, 2023 19:49 ET
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Director LIU VIVIAN H
Aug 15, 2023 19:44 ET
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Donofrio John Jr.
Aug 15, 2023 19:39 ET
Aytu BioPharma | 4: Statement of changes in beneficial ownership of securities-Director DOCKERY CARL
Aug 15, 2023 19:38 ET
No Data
No Data